We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » KV Cuts Deals With FemmePharma, Strides Arcolab for Drug-Marketing Rights
KV Cuts Deals With FemmePharma, Strides Arcolab for Drug-Marketing Rights
May 11, 2005
KV Pharmaceuticals will acquire worldwide marketing rights to an endometriosis treatment as well as U.S. and Canadian marketing rights for 10 generic drugs as a result of two recent deals.